Skip to main content
RACS ASC 2025
Combination of Lenvatinib and Pembrolizumab as neoadjuvant treatment for BRAF negative anaplastic thyroid cancer
Poster
Presenters
Authors
Authors

Dr Jie Zhao - , Dr Bella Nguyen - , Dr Dean Lisewski -